Pulmonary magnetic resonance imaging of obstructive airways disease

M. Kirby, A. M. Owrangi, J. X. Wang, S. Costella, S. Choy, D. G. Mccormack, G. Parraga

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

During the past several years, pulmonary magnetic resonance imaging (MRI) methods have been developed for the evaluation of obstructive lung disease including conventional proton (1H) MRI approaches, that are widely available, and more specialized methods involving inhaled oxygen or hyperpolarized noble gas contrast agents, that have somewhat more limited availability with access restricted mainly to specialized MRI research centers. These non-invasive pulmonary imaging approaches are currently under development to provide coincident structural and functional measurements of the lung parenchyma and airways in both asthma and chronic obstructive lung disease (COPD) because of the dire need for new sensitive, precise and regional in vivo measurements of disease progression and response to therapy. Therefore, this review focuses on the stateof-the-art MRI and its application to clinical pulmonary research of COPD and asthma with a focus on the potential of these imaging methods and their challenges in demonstrating new types of information that might influence clinical decision making. Particular attention is given to the relative sensitivity, precision and practicality of the methods and the overall strengths and challenges of MRI applications compared to well-established pulmonary imaging techniques. Finally we summarize emerging imaging physics developments with high potential for clinical translation to asthma and COPD.

Original languageEnglish (US)
Pages (from-to)17-29
Number of pages13
JournalMinerva Pneumologica
Volume50
Issue number1
StatePublished - Mar 1 2011

Fingerprint

Chronic Obstructive Pulmonary Disease
Magnetic Resonance Imaging
Lung
Asthma
Noble Gases
Obstructive Lung Diseases
Physics
Art
Research
Contrast Media
Disease Progression
Protons
Oxygen
Therapeutics

Keywords

  • Lung diseases
  • Lung diseases, obstructive
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Kirby, M., Owrangi, A. M., Wang, J. X., Costella, S., Choy, S., Mccormack, D. G., & Parraga, G. (2011). Pulmonary magnetic resonance imaging of obstructive airways disease. Minerva Pneumologica, 50(1), 17-29.

Pulmonary magnetic resonance imaging of obstructive airways disease. / Kirby, M.; Owrangi, A. M.; Wang, J. X.; Costella, S.; Choy, S.; Mccormack, D. G.; Parraga, G.

In: Minerva Pneumologica, Vol. 50, No. 1, 01.03.2011, p. 17-29.

Research output: Contribution to journalReview article

Kirby, M, Owrangi, AM, Wang, JX, Costella, S, Choy, S, Mccormack, DG & Parraga, G 2011, 'Pulmonary magnetic resonance imaging of obstructive airways disease', Minerva Pneumologica, vol. 50, no. 1, pp. 17-29.
Kirby M, Owrangi AM, Wang JX, Costella S, Choy S, Mccormack DG et al. Pulmonary magnetic resonance imaging of obstructive airways disease. Minerva Pneumologica. 2011 Mar 1;50(1):17-29.
Kirby, M. ; Owrangi, A. M. ; Wang, J. X. ; Costella, S. ; Choy, S. ; Mccormack, D. G. ; Parraga, G. / Pulmonary magnetic resonance imaging of obstructive airways disease. In: Minerva Pneumologica. 2011 ; Vol. 50, No. 1. pp. 17-29.
@article{cd997144ef5e4aa3be0e845c6b9d1607,
title = "Pulmonary magnetic resonance imaging of obstructive airways disease",
abstract = "During the past several years, pulmonary magnetic resonance imaging (MRI) methods have been developed for the evaluation of obstructive lung disease including conventional proton (1H) MRI approaches, that are widely available, and more specialized methods involving inhaled oxygen or hyperpolarized noble gas contrast agents, that have somewhat more limited availability with access restricted mainly to specialized MRI research centers. These non-invasive pulmonary imaging approaches are currently under development to provide coincident structural and functional measurements of the lung parenchyma and airways in both asthma and chronic obstructive lung disease (COPD) because of the dire need for new sensitive, precise and regional in vivo measurements of disease progression and response to therapy. Therefore, this review focuses on the stateof-the-art MRI and its application to clinical pulmonary research of COPD and asthma with a focus on the potential of these imaging methods and their challenges in demonstrating new types of information that might influence clinical decision making. Particular attention is given to the relative sensitivity, precision and practicality of the methods and the overall strengths and challenges of MRI applications compared to well-established pulmonary imaging techniques. Finally we summarize emerging imaging physics developments with high potential for clinical translation to asthma and COPD.",
keywords = "Lung diseases, Lung diseases, obstructive, Magnetic resonance imaging",
author = "M. Kirby and Owrangi, {A. M.} and Wang, {J. X.} and S. Costella and S. Choy and Mccormack, {D. G.} and G. Parraga",
year = "2011",
month = "3",
day = "1",
language = "English (US)",
volume = "50",
pages = "17--29",
journal = "Minerva Pneumologica",
issn = "0026-4954",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Pulmonary magnetic resonance imaging of obstructive airways disease

AU - Kirby, M.

AU - Owrangi, A. M.

AU - Wang, J. X.

AU - Costella, S.

AU - Choy, S.

AU - Mccormack, D. G.

AU - Parraga, G.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - During the past several years, pulmonary magnetic resonance imaging (MRI) methods have been developed for the evaluation of obstructive lung disease including conventional proton (1H) MRI approaches, that are widely available, and more specialized methods involving inhaled oxygen or hyperpolarized noble gas contrast agents, that have somewhat more limited availability with access restricted mainly to specialized MRI research centers. These non-invasive pulmonary imaging approaches are currently under development to provide coincident structural and functional measurements of the lung parenchyma and airways in both asthma and chronic obstructive lung disease (COPD) because of the dire need for new sensitive, precise and regional in vivo measurements of disease progression and response to therapy. Therefore, this review focuses on the stateof-the-art MRI and its application to clinical pulmonary research of COPD and asthma with a focus on the potential of these imaging methods and their challenges in demonstrating new types of information that might influence clinical decision making. Particular attention is given to the relative sensitivity, precision and practicality of the methods and the overall strengths and challenges of MRI applications compared to well-established pulmonary imaging techniques. Finally we summarize emerging imaging physics developments with high potential for clinical translation to asthma and COPD.

AB - During the past several years, pulmonary magnetic resonance imaging (MRI) methods have been developed for the evaluation of obstructive lung disease including conventional proton (1H) MRI approaches, that are widely available, and more specialized methods involving inhaled oxygen or hyperpolarized noble gas contrast agents, that have somewhat more limited availability with access restricted mainly to specialized MRI research centers. These non-invasive pulmonary imaging approaches are currently under development to provide coincident structural and functional measurements of the lung parenchyma and airways in both asthma and chronic obstructive lung disease (COPD) because of the dire need for new sensitive, precise and regional in vivo measurements of disease progression and response to therapy. Therefore, this review focuses on the stateof-the-art MRI and its application to clinical pulmonary research of COPD and asthma with a focus on the potential of these imaging methods and their challenges in demonstrating new types of information that might influence clinical decision making. Particular attention is given to the relative sensitivity, precision and practicality of the methods and the overall strengths and challenges of MRI applications compared to well-established pulmonary imaging techniques. Finally we summarize emerging imaging physics developments with high potential for clinical translation to asthma and COPD.

KW - Lung diseases

KW - Lung diseases, obstructive

KW - Magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=79957584041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957584041&partnerID=8YFLogxK

M3 - Review article

VL - 50

SP - 17

EP - 29

JO - Minerva Pneumologica

JF - Minerva Pneumologica

SN - 0026-4954

IS - 1

ER -